维生素D之外的半条太阳:非依赖通路有没有自己的纬度梯度

Written by

in

Language

Evidence level: B

太阳照在皮肤上的免疫效应,维生素D只解释了一部分。那”另一部分”——β-defensin-2、干扰素信号、光产物通路——它自己有没有随纬度和季节波动?这个检验真正的难点不是”存不存在”,而是你拿哪把尺子、在哪块组织上量。

正文

上一篇文章我们把”太阳的免疫效应,维生素D只能解释一半”这件事拆开了。这一篇往前走一步:那”另一半”——不依赖维生素D的那条通路——它自己有没有纬度梯度和季节调制?如果有,它在哪里才看得见?

先说结论的形态。这个检验真正的难点,不是”存不存在第二条通路”(这个已被坐实),而是你拿哪把尺子、在哪块组织上量。尺度错了,第二条通路不但看不见,还会显示成反号。

第一层差异:位置。 依赖通路是全身性的——维生素D经肝脏、肾脏羟化后进循环,能作用到任何表达VDR的组织。非依赖通路恰恰相反:它主要发生在皮肤局部,是光产物(DNA氧化、脂质过氧化、色氨酸代谢物)在角质细胞里就地引发的。这一点在2017年Ponda团队的随机对照试验里被量化得非常干脆(PMID 28228421):118名维生素D缺乏的成年人分两组,一组口服维生素D3(n=60),一组做窄谱UVB照射(n=58),持续六个月。抽血与取皮肤做转录组测序后发现,口服维生素D3在血和皮肤里都把干扰素-α、干扰素-γ响应基因集显著上调,而UVB恰恰把它们显著下调——方向完全相反,且血和皮肤一致。

也就是说,如果拿”血液里的干扰素信号强度”当非依赖通路的代理指标,测到的其实是UVB在皮肤里引发的那套免疫抑制的下游,符号是反的。”多纬度同步测抗菌肽与干扰素”听起来简单,做起来处处是坑:采血点和皮肤活检可能给出两个方向的答案。

第二层差异:作用光谱,进而纬度的作用方式。 维生素D合成是窄窗反应——7-脱氢胆固醇只在290-315 nm的UVB被有效转化,且有明显阈值行为:太阳高度角一低,UVB穿过大气层的路径变长,短波被削掉,合成基本停摆。而驱动非依赖通路的光产物,对UVA(315-400 nm)同样敏感。关键数字:到达地面的紫外线里,九成以上是UVA,维生素D有效的那一小段只占百分之几。

这带来一个很少被明说的推论:纬度不应该等比例缩放两条通路,它应该改变两条通路的比值。 低纬正午UVB充足,两条通路同时被拉动;高纬或冬季UVB断供而UVA仍在,依赖通路塌陷、非依赖通路相对占比上升。若此推论成立,”依赖通路 : 非依赖通路”的比值本身就带纬度梯度——这比”两条通路各自有没有梯度”锋利得多,也更可证伪。

最强的间接证据来自结局侧。 2011年Lucas等人在澳大利亚做的多中心病例对照研究(PMID 21300969,216例首次脱髓鞘事件/395对照,纬度27°S-43°S)发现:累积休闲日照每增加1,000 kJ/m²,风险比0.70(95% CI 0.53-0.94);光化损伤最高等级OR 0.39(0.17-0.92);血清25(OH)D每升高10 nmol/L,OR 0.93(0.86-1.00)。三者独立关联风险,加起来解释了从低纬到高纬发病率上升的32.4%。2018年MS Sunshine研究(PMID 29495467)把这件事推到更硬的位置:在黑人(116例/131对照)与西班牙裔(183/197)里,血清25(OH)D与多发性硬化风险完全没有关联,而终身紫外线暴露仍然保护(黑人OR 0.53,白人OR 0.68)。这直接挑战”维生素D缺乏是致病原因”的可信度——如果D是唯一中介,深肤色人群的关联不该凭空消失。

但直接测量从未做过。 上述全是结局侧推理:我们看到紫外线在某人群里保护、而25(OH)D不解释这件事,于是推断存在非依赖通路。真正需要的是一张多纬度站点的同步横断面——同一季节窗口,在不同纬度各站点同时测皮肤抗菌肽(HBD2、psoriasin)、干扰素信号、血清25(OH)D与个体化UVB通量。目前最接近的是2024年Clark在塔斯马尼亚霍巴特(42.8°S)的跨季小样本研究(PMID 39648192):29名女性夏冬两次采血,夏季Treg/CD4+更高(7.3% vs 7.0%,p=0.004),记忆型Treg同向,Th17不变;女性夏季户外时长与Th17负相关(r=-0.53)。样本小、单一纬度、单一性别,只能算一个方向的苗头。

反方压力必须摆上桌。 若非依赖通路真在人群层面扛事,我们该看到补维生素D的试验失败。确实失败了:D-Health试验15,373人、每月60,000 IU、随访五年,急性呼吸道感染OR 0.98(0.93-1.02),风险零降低(PMID 33444565);因感染住院IRR 0.95(0.86-1.05)(PMID 36811576);美国VITAL试验15,804人、每天2,000 IU,上呼吸道感染OR 0.96(0.86-1.06)(PMID 38113446)。这些阴性结果与”非依赖通路存在”相容——因为补剂本就模拟不了UVB。但另一组证据给出同等反压:UVB与口服D3在提升25(OH)D上可比(窄谱UVB每周三次19.2→75 nmol/L,对比每天1600 IU口服23.3→60.6 nmol/L,PMID 22632734)。而且我们知道自己不知道中介物是什么:候选的尿刊酸异构化已被排除——UVB把皮肤顺式尿刊酸拉高30%以上,但单独给顺式尿刊酸完全不能复现UVB对EAE的保护(PMID 28056806);而UVB的保护在既不能合成维生素D前体、又缺VDR的小鼠身上完整保留(PMID 31636184)。

所以可测预测是这样。 若非依赖通路确有独立的纬度调制,一张多纬度同步横断面应显示:① 控制血清25(OH)D后,皮肤抗菌肽与干扰素信号仍随纬度/局地UVB通量系统性变化;② 两条通路的比值随纬度单调移动,且方向与UVA:UVB比值变化一致,而非与总辐照一致;③ 高纬冬季出现”依赖通路塌陷、非依赖通路相对保留”的解离形态。若三点都不出现,现存结局侧推理需要一个别的解释。

证据与局限

已验证:
– 两条通路可被同一束UV分离:口服D3与UVB对干扰素响应基因集方向相反(PMID 28228421);UVB诱导HBD2等抗菌肽不经维生素D(PMID 19342087)。
– 非依赖通路不依赖维生素D及其受体:UVB对EAE的保护在无维生素D前体、无VDR小鼠中完整保留(PMID 31636184、PMID 20308557)。
– 结局侧存在独立的紫外线效应:日照/光化损伤与25(OH)D各自独立关联CNS脱髓鞘风险(PMID 21300969),且深肤色人群中25(OH)D关联消失而紫外线关联保留(PMID 29495467)。
– 补维生素D试验人群层面阴性(PMID 33444565、PMID 36811576、PMID 38113446)。

部分验证:
– 非依赖通路的季节调制有单纬度小样本迹象(Treg夏季升高、Th17不变,PMID 39648192),但样本小、无纬度对照。
– 两条通路的作用光谱差异(UVB窄窗 vs UVA主导)机制清楚,但”比值随纬度移动”尚未被任何人体研究直接测量。

待验证:
– 多纬度同步横断面中,控制25(OH)D后抗菌肽与干扰素信号的纬度/季节效应。
– 两条通路比值的纬度单调性,及其与UVA:UVB比值的对应关系。
– 高纬冬季”依赖塌陷、非依赖保留”的解离形态是否存在。
– 非依赖通路的实际中介物仍未识别(尿刊酸异构化已被排除,PMID 28056806)。

相关阅读

证据等级: B
参考文献: PMID 28228421, PMID 19342087, PMID 31636184, PMID 20308557, PMID 21300969, PMID 29495467, PMID 39648192, PMID 33444565, PMID 36811576, PMID 38113446, PMID 22632734, PMID 28056806, PMID 28078341, PMID 21852793, PMID 31593303


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Beyond Vitamin D: Do Non-Dependent Pathways Have Their Own Latitudinal Gradients

Evidence level: B

The immune effects of solar radiation on the skin are only partially explained by Vitamin D. What constitutes “the other part”—β-defensin-2, interferon signaling, photoproduction pathways—does it exhibit its own latitudinal and seasonal modulation? The true difficulty of this inquiry is not whether a second pathway exists (which is now established), but which measuring stick to use and which tissue to measure.

Main Text

In the previous article, we deconstructed the proposition that “Vitamin D explains only half of the sun’s immune effects.” This article advances further: does that “other half”—the pathway independent of Vitamin D—possess its own latitudinal gradient and seasonal modulation? If so, where does it become visible?

First, the form of the conclusion. The true difficulty lies not in confirming “the existence of a second pathway” (now established), but which measuring stick to use and which tissue to measure. If the scale is incorrect, the second pathway remains invisible or manifests with an inverted sign.

First Layer of Difference: Location. The dependent pathway is systemic—Vitamin D undergoes hydroxylation in the liver and kidneys, enters circulation, and acts on any tissue expressing VDR. Conversely, the non-dependent pathway occurs primarily locally in the skin, triggered by photoproducts (DNA oxidation, lipid peroxidation, tryptophan metabolites) within keratinocytes. This distinction was quantified clearly in a randomized controlled trial by Ponda et al. (2017, PMID 28228421): 118 adults with Vitamin D deficiency were divided into two groups, one receiving oral Vitamin D3 (n=60) and the other undergoing narrow-band UVB irradiation (n=58) for six months. Blood draws and skin biopsies followed by transcriptome sequencing revealed that oral Vitamin D3 significantly upregulated interferon-α and interferon-γ response gene sets in both blood and skin, whereas UVB significantly downregulated them—the direction was completely opposite, consistent between blood and skin.

Consequently, if “interferon signal intensity in blood” is used as a proxy for the non-dependent pathway, the measurement actually reflects the downstream immune suppression triggered by UVB in the skin, with an inverted sign. “Simultaneous multi-latitude measurement of antimicrobial peptides and interferon” sounds simple but is fraught with pitfalls: blood draws and skin biopsies may yield answers pointing in opposite directions.

Second Layer of Difference: Action Spectrum and the Mechanism of Latitudinal Effect. Vitamin D synthesis is a narrow-window reaction—7-dehydrocholesterol is effectively converted only by UVB in the 290-315 nm range, exhibiting clear threshold behavior: as solar elevation decreases, the atmospheric path length increases, short waves are attenuated, and synthesis essentially halts. In contrast, the photoproducts driving the non-dependent pathway are equally sensitive to UVA (315-400 nm). Key figure: among ultraviolet rays reaching the ground, over 90% is UVA, while the narrow band effective for Vitamin D accounts for only a few percent.

This leads to a rarely explicit inference: latitude should not scale both pathways proportionally; it should alter their ratio. At low latitudes at noon, UVB is abundant, pulling both pathways simultaneously; at high latitudes or in winter, UVB supply collapses while UVA persists, causing the dependent pathway to collapse and the non-dependent pathway’s relative proportion to rise. If this inference holds, the ratio of “Dependent Pathway : Non-Dependent Pathway” itself carries a latitudinal gradient—a sharper and more falsifiable metric than asking if each pathway individually possesses a gradient.

The Strongest Indirect Evidence Comes from the Outcome Side. A multicase-control study by Lucas et al. (2011, PMID 21300969) in Australia (216 first demyelinating events/395 controls, latitudes 27°S-43°S) found that for every 1,000 kJ/m² increase in cumulative leisure sunlight exposure, the odds ratio was 0.70 (95% CI 0.53-0.94); for the highest grade of photochemical damage, OR 0.39 (0.17-0.92); and for every 10 nmol/L increase in serum 25(OH)D, OR 0.93 (0.86-1.00). All three independently associated with risk, collectively explaining 32.4% of the rise in incidence from low to high latitudes. The MS Sunshine study (2018, PMID 29495467) pushed this to a harder position: in Black (116 cases/131 controls) and Hispanic (183/197) populations, serum 25(OH)D showed no association with multiple sclerosis risk, while lifetime UV exposure remained protective (Black OR 0.53, White OR 0.68). This directly challenges the credibility of “Vitamin D deficiency as the causative agent”—if D were the sole mediator, the association should not vanish in dark-skinned populations.

However, direct measurement has never been conducted. The above are all outcome-side inferences: we observe protection by UV in certain populations while 25(OH)D fails to explain it, thus inferring a non-dependent pathway. What is truly needed is a synchronous cross-sectional study across multiple latitudes—measuring skin antimicrobial peptides (HBD2, psoriasin), interferon signals, serum 25(OH)D, and individualized UVB flux across sites in the same seasonal window. The closest approach is a small-sample, cross-seasonal study by Clark in Hobart, Tasmania (42.8°S) in 2024 (PMID 39648192): 29 women sampled twice, summer showing higher Treg/CD4+ ratios (7.3% vs 7.0%, p=0.004), memory Tregs moving in the same direction, Th17 unchanged; female outdoor duration negatively correlated with Th17 (r=-0.53). Small sample size, single latitude, and single gender mean this can only be considered a preliminary signal in one direction.

Counter-Pressure Must Be Placed on the Table. If a non-dependent pathway truly sustains effects at the population level, we should observe failures in Vitamin D supplementation trials. Indeed, they failed: The D-Health trial (15,373 people, 60,000 IU monthly, 5-year follow-up) showed no reduction in acute respiratory infection OR (0.98, 0.93-1.02) and no reduction in hospitalization due to infection IRR (0.95, 0.86-1.05) (PMID 33444565, PMID 36811576); the US VITAL trial (15,804 people, 2,000 IU daily) showed no reduction in upper respiratory infection OR (0.96, 0.86-1.06) (PMID 38113446). These negative results are compatible with “the existence of a non-dependent pathway”—because supplements do not mimic UVB. However, another set of evidence provides equal counter-pressure: UVB and oral D3 are comparable in raising 25(OH)D (narrow-band UVB three times weekly raised levels from 19.2 to 75 nmol/L, compared to daily 1600 IU oral raising from 23.3 to 60.6 nmol/L, PMID 22632734). Moreover, we know what we do not know regarding the mediator: the candidate uracil diol isomerization has been excluded—UVB raises skin cis-uracil diol by over 30%, yet administering cis-uracil diol alone fails to replicate UVB’s protection in EAE models (PMID 28056806); conversely, UVB’s protection is fully retained in mice unable to synthesize Vitamin D precursors and lacking VDR (PMID 31636184).

Therefore, the measurable prediction is as follows. If a non-dependent pathway indeed possesses independent latitudinal modulation, a multi-latitude synchronous cross-sectional study should reveal: ① After controlling for serum 25(OH)D, skin antimicrobial peptides and interferon signals still show systematic variation with latitude/local UVB flux; ② The ratio of the two pathways shifts monotonically with latitude, moving in alignment with the UVA:UVB ratio rather than total irradiance; ③ A dissociated morphology appears in high-latitude winter where the “dependent pathway collapses while the non-dependent pathway is relatively preserved.” If none of these three points appear, existing outcome-side inferences require an alternative explanation.

Evidence and Limitations

Verified:
– Two pathways can be separated by the same UV beam: Oral D3 and UVB show opposite directions on interferon response gene sets (PMID 28228421); UVB induces antimicrobial peptides like HBD2 independent of Vitamin D (PMID 19342087).
– The non-dependent pathway does not rely on Vitamin D or its receptor: UVB protection in EAE is fully retained in mice lacking Vitamin D precursors and VDR (PMID 31636184, PMID 20308557).
– Independent UV effects exist at the outcome level: Sunlight/photochemical damage and 25(OH)D independently associate with CNS demyelination risk (PMID 21300969), and in dark-skinned populations, the 25(OH)D association vanishes while UV exposure remains protective (PMID 29495467).
– Vitamin D supplementation trials show negative results at the population level (PMID 33444565, PMID 36811576, PMID 38113446).

Partially Verified:
– Seasonal modulation of the non-dependent pathway shows signs in single-latitude small samples (Treg increase in summer, Th17 unchanged, PMID 39648192), but sample size is small with no latitudinal controls.
– The mechanism of differing action spectra (UVB narrow window vs UVA dominance) is clear, but “ratio shifting with latitude” has not been directly measured in any human study.

To Be Verified:
– Latitudinal/seasonal effects on antimicrobial peptides and interferon signals in multi-latitude synchronous cross-sections after controlling for 25(OH)D.
– Monotonicity of the two-pathway ratio with latitude and its correspondence with the UVA:UVB ratio.
– Existence of the dissociated morphology in high-latitude winter (“dependent collapse, non-dependent retention”).
– The actual mediator of the non-dependent pathway remains unidentified (uracil diol isomerization excluded, PMID 28056806).

Related Reading

Evidence Level: B
References: PMID 28228421, PMID 19342087, PMID 31636184, PMID 20308557, PMID 21300969, PMID 29495467, PMID 39648192, PMID 33444565, PMID 36811576, PMID 38113446, PMID 22632734, PMID 28056806, PMID 28078341, PMID 21852793, PMID 31593303


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *